Zavicefta Europska Unija - hrvatski - EMA (European Medicines Agency)

zavicefta

pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterijski lijekovi za sistemsku primjenu, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

Imprida Europska Unija - hrvatski - EMA (European Medicines Agency)

imprida

novartis europharm ltd - valsartan, amlodipine (as amlodipine besilate) - hipertenzija - sredstva koja djeluju na sustav renin-angiotenzina - liječenje esencijalne hipertenzije. imprida indiciran kod pacijenata kod kojih je krvni pritisak nije dovoljno prati na amlodipin ili валсартан kao monoterapija.

Recarbrio Europska Unija - hrvatski - EMA (European Medicines Agency)

recarbrio

merck sharp & dohme b.v.  - monohidrat Имипенем, циластатин natrija, relebactam monohidrat - Грамотрицательные bakterijske infekcije - carbapenems, antibacterials for systemic use, - recarbrio is indicated for:- treatment of hospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap), in adults (see sections 4. 4 i 5. - treatment of bacteraemia that occurs in association with, or is suspected to be associated with hap or vap, in adults. - treatment of infections due to aerobic gram-negative organisms in adults with limited treatment options (see sections 4. 2, 4. 4 i 5. treba uzeti u obzir formalne preporuke za odgovarajuće korištenje antibakterijskih posrednika.

Darzalex Europska Unija - hrvatski - EMA (European Medicines Agency)

darzalex

janssen-cilag international n.v. - daratumumab - multipli mijelom - monoclonal antibodies and antibody drug conjugates, antineoplastic agents - multiple myelomadarzalex is indicated: in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. u kombinaciji s бортезомибом, талидомидом i дексаметазоном za liječenje odraslih bolesnika s prvi put utvrđenom multiplog mijeloma, koji imaju pravo za obavljanje autologna transplantacija matičnih stanica . u kombinaciji s леналидомидом i дексаметазоном i бортезомибом i дексаметазоном za liječenje odraslih bolesnika s multiplog mijeloma, koji je dobio barem jedne prethodne terapije. in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a proteasome inhibitor and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or after the last therapy (see section 5. u monoterapiji za liječenje odraslih bolesnika s ponavljajućom i uporan multiplog mijeloma, čija je ranije terapija je uključivala inhibitor протеасом i иммуномодулирующего agent i koji je pokazao napredovanje bolesti na zadnje terapije. al amyloidosisdarzalex is indicated in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic light chain (al) amyloidosis.

Vanflyta Europska Unija - hrvatski - EMA (European Medicines Agency)

vanflyta

daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.

NORPREXANIL 5 mg/5 mg tableta 5 mg/1 tableta+ 5 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

norprexanil 5 mg/5 mg tableta 5 mg/1 tableta+ 5 mg/1 tableta tableta

oktal pharma d.o.o. sarajevo - amlodipin, Периндоприл - tableta - 5 mg/1 tableta+ 5 mg/1 tableta - 1 tableta sadrži: 5 mg perindoprila (u obliku perindoprilarginina) i 5 mg amlodipina (u obliku amlodipinbesilata)

NORPREXANIL 5 mg/10 mg tableta 5 mg/1 tableta+ 10 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

norprexanil 5 mg/10 mg tableta 5 mg/1 tableta+ 10 mg/1 tableta tableta

oktal pharma d.o.o. sarajevo - amlodipin, Периндоприл - tableta - 5 mg/1 tableta+ 10 mg/1 tableta - 1 tableta sadrži: 5 mg perindoprila (u obliku perindoprilarginina) i 10 mg amlodipina (u obliku amlodipinbesilata)

NORPREXANIL 10 mg/5 mg tableta 10 mg/1 tableta+ 5 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

norprexanil 10 mg/5 mg tableta 10 mg/1 tableta+ 5 mg/1 tableta tableta

oktal pharma d.o.o. sarajevo - amlodipin, Периндоприл - tableta - 10 mg/1 tableta+ 5 mg/1 tableta - 1 tableta sadrži: 10 mg perindoprila (u obliku perindoprilarginina) i 5 mg amlodipina (u obliku amlodipinbesilata)

NORPREXANIL 10 mg/10 mg tableta 10 mg/1 tableta+ 10 mg/1 tableta tableta Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

norprexanil 10 mg/10 mg tableta 10 mg/1 tableta+ 10 mg/1 tableta tableta

oktal pharma d.o.o. sarajevo - amlodipin, Периндоприл - tableta - 10 mg/1 tableta+ 10 mg/1 tableta - 1 tableta sadrži: 10 mg perindoprila (u obliku perindoprilarginina) i 10 mg amlodipina (u obliku amlodipinbesilata)

Triplixam 2,5 mg/ 0,625 mg/ 5 mg filmom obložene tablete Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

triplixam 2,5 mg/ 0,625 mg/ 5 mg filmom obložene tablete

servier pharma d.o.o., tuškanova 37, zagreb - perindoprilum, indapamidum, amlodipinum - filmom obložena tableta - 2,5 mg + 0,625 mg + 5 mg - urbroj: jedna filmom obložena tableta sadrži 1,6975 mg perindoprila što odgovara 2,5 mg perindoprilarginina, 0,625 mg indapamida i 6,935 mg amlodipinbesilata što odgovara 5 mg amlodipina